Burden of gastroesophageal reflux disease. Evidence from a recent methodological study in Spain;Repercusión de la enfermedad en pacientes con reflujo gastroesofágico. Evidencia de un estudio metodológico reciente en España

Gastroenterologia y Hepatologia

Volumn 27, Issue 5, 2004, Pages 300-306

  Pique J M ^a   Kulich, K R ^b   Vegazo, O ^b   Jimenez J ^b   Zapardiel, J ^b   Carlsson, J ^b   Wiklund, I ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ANXIETY; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; EMOTIONAL STRESS; EVIDENCE BASED MEDICINE; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INDIGESTION; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PREVALENCE; QUALITY OF LIFE; SCORING SYSTEM; SELF REPORT; SOCIOECONOMICS; SPAIN; SYMPTOMATOLOGY;

EID: 2542494964     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13060689     Document Type: Article

References (51)

1. Katz PO. Gastroesophageal reflux disease - state of the art. Rev Gastroenterol Dis 2001;1:128-38.
2. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992;51:24-9.
3. Jasani K, Piterman L, McCall L. Gastroesophageal reflux and quality of life. Patient's knowledge, attitudes and perceptions. Aus Fam Physician 1999;28(Suppl 1):15-8.
4. Corder AP, Jones RH, Sadler GH, Daniels P, Johnson CD. Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice. Br J Clin Pract 1996;50:245-8.
5. Eisendrath P, Tack J, Deviere J. Diagnosis of gastroesophageal reflux disease in general practice: a Belgian national survey. Endoscopy 2002;34:998-1003.
6. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-56.
7. Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scan J Gastroenterol 1997;32:974-9.
8. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996;183:217-24.
9. Moyer CA, Fendrick AM. Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis 1998;16:315-24.
10. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
11. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess (Winchester, England) 1998;2:1-74.
12. Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96:S46-S53.
13. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001;96:1998-2004.
14. Kaspari S, Biedermann A, Mey J. Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease. Digestion 2001;63:163-70.
15. Prasad M, Rentz AM, Revicki DA. The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review. Pharmacoeconomics 2003;21:769-90.
16. Svedlund J, Sjodin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34.
17. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998;583:41-9.
18. Crawley J, Frank L, Joshua-Gotlib S, Flynn J, Frank S, Wiklund I. Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD. Dig Dis Sci 2001;46:571-80.
19. Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD) - results from a cross-sectional study. Value in Health 2002;5:106-13.
20. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
21. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
22. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83.
23. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes. The example of health-related quality of life - a european guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal 2002;36:209-38.
24. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-52.
25. Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 1996;221:8-13.
26. Kulich KR, Piqué JM, Vegazo O, Jiménez J, Zapardiel J, Carlsson J, et al. Psychometric Validation of the Spanish Translation of Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) Questionnaire in Patients with Reflux Disease. Rev Clin Exp [en prensa].
27. Kulich KR, Wiklund I, Junghard O. Factor structure of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire evaluated in patients with heartburn predominant reflux disease. Qual Life Res 2003;6:699-708.
28. Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1159-65.
29. Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1167-70.
30. Alonso J, Prieto L, Anto JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clinicos. Med Clin (Barc) 1995;104:771-6.
31. Alonso J, Prieto L, Ferrer M, Vilagut G, Broquetas JM, Roca J, et al. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of Life in COPD Study Group. J Clin Epidemiol 1998;51:1087-94.
32. Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, et al. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991;158:255-9.
33. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
34. Drummond HE, Ghosh S, Ferguson A, Brackenridge D, Tiplady B. Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study. Qual Life Res 1995;4:21-6.
35. Cary, NC. SAS Institute Inc. 8.02., 2001.
36. Miller RG. Simultaneous statistical inference. 2nd ed. New York: Springer-Verlag, 1981.
37. th Annual Conference of the International Society for Quality of Life Research, 1999; Barcelona, Spain.
38. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989;262:907-13.
39. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999;94:1782-9.
40. Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 1993;88:11-9.
41. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998;104:252-8.
42. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, et al. Quality of life in relation to symptoms in patients with gastroesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767-76.
43. Lind T, Havelund T, Glise H, Hernqvist H, Lauritsen K, Lundell L, et al. Omeprazole improves quality of life in patients with endoscopy negative reflux disease [abstract]. Gastroenterology 1995;108.
44. Wiklund I, Talley N. Update on health-related quality of life in patients with gastroesophageal reflux disease. Expert Review Pharmacoeconomics Outcomes Research 2003;3:341-50.
45. Jones R, Bytzer P. Review article: acid suppression in the management of gastro-oesophageal reflux disease - an appraisal of treatment options in primary care. Aliment Pharmacol Ther 2001;15:765-72.
46. Talley N, Junghard OIW. Why do patients with gastroesophageal reflux disease (GERD) have poor quality of life (HRQL)? [abstract]. Gastroenterology 2001;120.
47. Lauritsen K, Junghard O, Eklund SIW. The effect of esomeprazole 40 mg on healing, reflux symptoms and quality of life in patients with reflux esophagitis [abstract]. Gastroenterology 2002;122.
48. Wiklund I, Hansen ÅN, Bergenheim R, Mourn B. Esomeprazole is superior to ranitidine 150 mg bid in maintaining quality of life (QoL) in patients with symptomatic GERD. Scand J Gastroenterol 2003;38(Suppl 238):22.
49. Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 2003;98:S31-S9.
50. Quigley EM. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003;98:S24-S30.
51. Marzo M, Alonso P, Bonfill X, Fernández M, Ferrándiz J, Martínez G, et al. Clinical practice guideline on the management of patients with gastroesophageal reflux disease (GERD). Gastroenterol Hepatol 2002;25:85-110.